Principal Financial Group Inc 2seventy Bio, Inc. Transaction History

Principal Financial Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$3.09 - $6.0 $5,385 - $10,458	-1,743 Reduced 10.84%	14,337 $76,000
Q4 2023 Feb 07, 2024	SELL	$1.57 - $4.58 $299 - $874	-191 Reduced 1.17%	16,080 $68,000
Q3 2023 Nov 02, 2023	SELL	$3.14 - $11.2 $1,544 - $5,510	-492 Reduced 2.94%	16,271 $63,000
Q2 2023 Aug 07, 2023	BUY	$8.45 - $12.48 $37,779 - $55,798	4,471 Added 36.37%	16,763 $169,000
Q1 2023 May 09, 2023	BUY	$9.21 - $14.98 $12,792 - $20,807	1,389 Added 12.74%	12,292 $125,000
Q4 2022 Feb 09, 2023	BUY	$8.57 - $17.0 $5,261 - $10,438	614 Added 5.97%	10,903 $102,000
Q3 2022 Nov 09, 2022	BUY	$12.56 - $17.54 $129,229 - $180,469	10,289 New	10,289 $149,000
Q1 2022 May 09, 2022	SELL	$11.67 - $26.72 $901,390 - $2.06 Million	-77,240 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$13.77 - $42.56 $1.06 Million - $3.29 Million	77,240 New	77,240 $1.98 Million

122

48.2M

211K

9.7K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $187M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.